title: The crystalloid cardioplegia: advantages with a word of caution.
abstract: Technical success and absence of iatrogenic injury from inadequate myocardial protection are the foremost targets of every cardiac surgical procedure. The current trends of pediatric cardiac surgery are aimed to achieve definitive repair of complex cardiac defects at birth as to avoid the risks related with palliative surgery and to reduce the long term impact of the untreated defect on the cardiac function. Thus, even newborn patients are exposed to a prolonged time of myocardial ischemia. The aim of this paper is to describe the impact of crystalloid HKT Custodiol cardioplegia infusion on myocardial protection in the early and late outcome of newborn patients who underwent arterial switch operation (ASO) for transposition of the great arteries (TGA).
authors.affiliation: Pediatric and Congenital Adult Cardiac Surgery Unit, S Orsola-Malpighi University Hospital, Bologna, Italy. manuangeli@libero.it
authors.forename: E
authors.initials: E
authors.lastname: Angeli
mesh_terms: D006348:Cardiac Surgical Procedures / Q000009:adverse effects / Q000379:methods*; D002315:Cardiopulmonary Bypass / Q000295:instrumentation / Q000379:methods; D003422:Critical Care; D000077324:Crystalloid Solutions; D015199:Extracorporeal Membrane Oxygenation; D006324:Heart Arrest, Induced / Q000379:methods*; D006330:Heart Defects, Congenital / Q000601:surgery; D006801:Humans; D007231:Infant, Newborn; D007431:Intraoperative Complications / Q000517:prevention & control; D007552:Isotonic Solutions / Q000009:adverse effects / Q000627:therapeutic use*; D007902:Length of Stay; D017202:Myocardial Ischemia / Q000517:prevention & control; D010952:Plasma Substitutes / Q000009:adverse effects / Q000627:therapeutic use*; D012189:Retrospective Studies; D019210:Troponin I / Q000097:blood
chemical_list: D000077324:Crystalloid Solutions; D007552:Isotonic Solutions; D010952:Plasma Substitutes; D019210:Troponin I